Malaria ppt

DrHeena tiwari
DrHeena tiwaripublic health student
MALARIA
PRESENTER
Dr. HEENA DIXIT
GUIDE
Dr. KRUPALI PATEL
05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 1
CONTENTS
• INTRODUCTION
• PROBLEM STATEMENT
• EPIDEMIOLOGICAL TYPES
• EPIDEMIOLOGICAL DETERMINANTS
• MEASUREMENT
• DISEASE CONTROL
• INTERVENTIONS
• GLOBAL STRATEGY
05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 2
INTRODUCTION
05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 3
PROBLEM STATEMENT- WORLD
• 2016- 91 COUNTIRES- 216 MILLION CASES- 4,45,000 DEATHS
• 2010 TO 2016- 18% DECREASE IN INCIDENCE AMONG POPULATION AT RISK
GLOBALLY.
• MAXIMUM BURDEN- SUB SHARAN REGION
• RISK GROUPS:
• YOUNG CHILDRENS
• NON / SEMI IMMUNE/ HIV- PREGNANT WOMEN
• AIDS PATIENTS
• INTERNATIONAL TRAVELLERS
• IMMIGRANT & FAMILY- NON ENDEMIC AREAS
• ETHNIC & TRIBALS
05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 4
PROBLEM STATEMENT- INDIA
• India shared 2% of the total global malaria cases in 2019
• PALSMODIUM FALCIPARUM
• 21.98% POPULATION- HIGH TRANSMISSION AREAS (>1:1000 RATIO)
• 67% POPULATION- LOW TRANSMISSION AREAS (0-1:1000 RATIO)
• 91% CASES & 99% DEATHS- NORTH EAST & CENTRAL REGION
• 2000-2013- CASES DECLINE BY 58.63%- 2.03 TO 0.84 MILLION
• 2000-2013- DEATH DECLINE BY 88.85%- 932 TO 104 ANNUALLY
• 1° VECTORS- An. Culicifacies. An. Stephensi, An. Fluviatilis, An. Minimus, An. Birus, An.
Epiroticus.
05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 5
EPIDEMIOLOGICAL TYPES
• TRIBAL
• RURAL
• URBAN
• PROJECT AREA
• BORDER
• FOREST
• FLOODS
05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 6
EPIDEMIOLOGICAL DETERMINANTS
AGENT FACTORS
• AGENT
• RESERVOIR OF
INFECTION
• PERIOD OF
COMMUNICABILITY
HOST FACTORS
• AGE
• SEX
• RACE
• PREGNANCY
• SOCIOECONOMIC
DEVELOPMENT
• HOUSING
• POPULATION MOBILITY
• OCCUPATION
• HUMAN HABITS
• IMMUNITY
ENVIRONMENTAL
FACTORS
• SEASON
• TEMPRATURE
• HUMIDITY
• RAINFALL
• ALTITUDE
• MAN MADE MALARIA
05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 7
MODE OF TRANSMISSION
• VECTOR
• DIRECT
• CONGENITAL
05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 8
INCUBATION PERIODS
• FALCIPARUM- 12 DAYS (9 TO 14)
• VIVAX- 14 DAYS (8 TO 17)
• QUARTAN- 28 DAYS (18 TO 40)
• OVALE- 17 DAYS (6 TO 18)
• VIVAX- FEW STRAINS- 9 MONTHS (UNDER SUPPRESSIVE ANTIMALARIAL
DRUGS)
CLINICAL FEATURES DIAGNOSIS
• MICROSCOPY
• SEROLOGICAL TEST
• RAPID DIAGNOSTIC TEST
05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 9
MEASUREMENT
• PRE ERADICATION ERA
• SPLEEN RATE
• AVERAGE ENLARGED SPLEEN
• PARASITE RATE
• PARASITE DENSITY INDEX
• INFANT PARASITE RATE
• PROPOTIONAL CASE RATE
05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 10
• ERADICATION ERA
• ANNUAL PARASITE INCIDENCE
• ANNUAL BLOOD EXMAINATION RATE
• ANNUAL FALCIPARUM INCIDENCE
• SLIDE POSITIVITY RATE
• SLIDE FALCIPARUM RATE
VECTOR INDICES
• HUMAN BLOOD INDEX
• SPOROZOITE RATE
• MOSQUITO DENSITY
• MAN BITING RATE
• ENOCULATION RATE
DISEASE CONTROL
05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 11
05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 12
05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 13
ACTIVE INTERVENTION MEASURES
05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 14
MALARIA VECTOR CONTROLL MEASURES
05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 15
GLOBAL STRATEGY- NMCP & VACCINES
05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 16
Global Malaria Elimination scenario:
• Since 1900, 127 countries have registered malaria elimination. In 2021, two
countries El Salvador on February 25 and China on June 29 were declared
malaria-free by the WHO.
• China followed some specific strategies, namely strong surveillance following
the ‘1-3-7’system: malaria diagnosis within 1 day, 3 days for case investigation
and by day 7 for public health responses.
• Molecular Malaria Surveillance for drug resistance and genome-based
approaches to distinguish between indigenous and imported cases was
conducted. All borders to the neighbouring countries were thoroughly
screened to prevent the entry of unwanted malaria into the country.
• Srilanka could achieve elimination by deploying malaria mobile clinics besides
strengthening surveillance system.
05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 17
NATIONAL MALARIA CONTROL PROGRAMME
• Began as NMCP in 1953.
• Following are main activities of NMCP:
• Formulating policies and guidelines.
• Technical guidance.
• Planning.
• Logistics.
• Monitoring and evaluation.
• Coordination of activities through the states/union Territories and in consultation with
national organisations such as National Centre for Disease Control National Institute of Malaria
Research.
• Collaboration with international oraganisations..
• Training
• Fascilitating research
• Coordinating control activities in the inter-state and inter-country border areas.
05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 18
MOSQUIRIX
• A recombinent protein based malaria vaccine
• WHO is recommending widespread use of the RTS,S/AS01 (RTS,S) malaria vaccine among
children in sub-Saharan Africa and in other regions with moderate to high P. falciparum
malaria transmission.
• Malaria vaccine should be provided in a schedule of 4 doses in
children from 5 months of age for the reduction of malaria
disease and burden.
05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 19
URBAN MALARIA SCHEME
• Launched in november 1971 to interrupt or reduce malaria
tranmission in towns and cities.
• Current strategy:
• Anti-larval measures on weekly intervals.
• Source reduction i.e.land filling/drainage through minor engineering
methods.
• Biological control by introduction of larvivorous fish.
• Anti-parasitic measures through passive surveillance for detection of
cases and complete treatment.
05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 20
TRIBAL MALARIA ACTION PLAN
• Predominant parasite species in triabl areis Falciparum.
• Objective is to reduce large reservoir of Falciparum in triabal population.
• Priority of villages according to degree of risk i.e.high proportion of Pf
cases, type of vectors,forest based economy,outdoor sleeping habits etc.
for vector control measures(IRS,LLINs or treatment of community owned
bed nets with insecticides), social marketing to increase spray
coverageandusage of bed nets, community mobilisation by utilising
traditional IEC/BCC tools practices.
• In Forest areas where accessibility of workers /volunteers is impeded due
to elephants , involvement of forest department in diagnosis and treatment
by deleneation of such areas can be explored.
05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 21
THANK YOU FOR YOUR PATIENCE LISTENING
WORLD MALARIA DAY 25TH APRIL YEARLY MALARIA WEEK -JUNE
05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 22
1 de 22

Recomendados

Epidemiological types of malaria por
Epidemiological types of malariaEpidemiological types of malaria
Epidemiological types of malariadrravimr
12.2K vistas47 diapositivas
Malaria ppt final por
Malaria ppt finalMalaria ppt final
Malaria ppt finalDr. Nitish kumar
2.5K vistas92 diapositivas
Malaria por
MalariaMalaria
MalariaTrishna Kattel
3.8K vistas108 diapositivas
Malaria ppt por
Malaria pptMalaria ppt
Malaria pptNoe Mendez
8.9K vistas17 diapositivas
MALARIA.pptx por
MALARIA.pptxMALARIA.pptx
MALARIA.pptxAnkit Gajjar
1.2K vistas36 diapositivas
Malaria(Plasmodium falciparum)- Epidemiology, Life Cycle, Prevention and Erad... por
Malaria(Plasmodium falciparum)- Epidemiology, Life Cycle, Prevention and Erad...Malaria(Plasmodium falciparum)- Epidemiology, Life Cycle, Prevention and Erad...
Malaria(Plasmodium falciparum)- Epidemiology, Life Cycle, Prevention and Erad...Sarath
12.9K vistas23 diapositivas

Más contenido relacionado

La actualidad más candente

Monkeypox por
MonkeypoxMonkeypox
MonkeypoxDr. Vijay Kumar Pathak
2.7K vistas10 diapositivas
Malaria por
MalariaMalaria
MalariaNikhil Aggarwal
5.1K vistas28 diapositivas
MALARIA TEACHING BASICS por
MALARIA TEACHING BASICS MALARIA TEACHING BASICS
MALARIA TEACHING BASICS Society for Microbiology and Infection care
8.9K vistas89 diapositivas
Malaria por
MalariaMalaria
MalariaSriloy Mohanty
3.2K vistas46 diapositivas
Malaria ppt. por
Malaria ppt.Malaria ppt.
Malaria ppt.Lajina Ghimire
81.7K vistas33 diapositivas
Rickettsial diseases seminar 2016 por
Rickettsial diseases seminar 2016Rickettsial diseases seminar 2016
Rickettsial diseases seminar 2016Dr. Mamta Gehlawat
3.5K vistas51 diapositivas

La actualidad más candente(20)

Naturally acquired plasmodium knowlesi malaria in human, thailand[1] por Prasit Chanarat
Naturally acquired plasmodium knowlesi malaria in human, thailand[1]Naturally acquired plasmodium knowlesi malaria in human, thailand[1]
Naturally acquired plasmodium knowlesi malaria in human, thailand[1]
Prasit Chanarat1.1K vistas
Neglected Tropical Diseases (NTDs) por Updesh Yadav
Neglected Tropical Diseases (NTDs)Neglected Tropical Diseases (NTDs)
Neglected Tropical Diseases (NTDs)
Updesh Yadav265 vistas
The Interaction between TB and HIV por meducationdotnet
The Interaction between TB and HIVThe Interaction between TB and HIV
The Interaction between TB and HIV
meducationdotnet1.9K vistas
Dengue epidemiology por Seema Verma
Dengue epidemiologyDengue epidemiology
Dengue epidemiology
Seema Verma2.4K vistas
Malaria rapid diagnostic tests by Dr. Basil Tumaini por Basil Tumaini
Malaria rapid diagnostic tests by Dr. Basil TumainiMalaria rapid diagnostic tests by Dr. Basil Tumaini
Malaria rapid diagnostic tests by Dr. Basil Tumaini
Basil Tumaini1.7K vistas
Measles .pptx por Beema3
Measles .pptxMeasles .pptx
Measles .pptx
Beema3125 vistas
WORLD TUBERCULOSIS DAY 2023 AWARENESS.pptx por anjalatchi
WORLD TUBERCULOSIS DAY 2023 AWARENESS.pptxWORLD TUBERCULOSIS DAY 2023 AWARENESS.pptx
WORLD TUBERCULOSIS DAY 2023 AWARENESS.pptx
anjalatchi1.5K vistas

Similar a Malaria ppt

HIV IN PREGNANCY 2017 por
HIV IN PREGNANCY 2017HIV IN PREGNANCY 2017
HIV IN PREGNANCY 2017Helen Madamba
5.6K vistas47 diapositivas
National Leprosy Eradication Programme por
National Leprosy Eradication ProgrammeNational Leprosy Eradication Programme
National Leprosy Eradication ProgrammePreethi Selvaraj
3K vistas58 diapositivas
8th jan 19 HIV & Hepatitis updates Part I por
8th jan 19 HIV & Hepatitis updates Part I8th jan 19 HIV & Hepatitis updates Part I
8th jan 19 HIV & Hepatitis updates Part IPawan KB Agrawal
144 vistas44 diapositivas
Nacp por
NacpNacp
Nacpfrank jc
35.2K vistas55 diapositivas
NATIONAL AIDS CONTROL PROGRAMME IN INDIA por
NATIONAL AIDS CONTROL PROGRAMME IN INDIANATIONAL AIDS CONTROL PROGRAMME IN INDIA
NATIONAL AIDS CONTROL PROGRAMME IN INDIABharat Masal
34.8K vistas95 diapositivas
DOH-PROGRAMS.pdf por
DOH-PROGRAMS.pdfDOH-PROGRAMS.pdf
DOH-PROGRAMS.pdfKheyaGwynRabago
637 vistas145 diapositivas

Similar a Malaria ppt(20)

HIV IN PREGNANCY 2017 por Helen Madamba
HIV IN PREGNANCY 2017HIV IN PREGNANCY 2017
HIV IN PREGNANCY 2017
Helen Madamba5.6K vistas
National Leprosy Eradication Programme por Preethi Selvaraj
National Leprosy Eradication ProgrammeNational Leprosy Eradication Programme
National Leprosy Eradication Programme
Preethi Selvaraj3K vistas
8th jan 19 HIV & Hepatitis updates Part I por Pawan KB Agrawal
8th jan 19 HIV & Hepatitis updates Part I8th jan 19 HIV & Hepatitis updates Part I
8th jan 19 HIV & Hepatitis updates Part I
Pawan KB Agrawal144 vistas
Nacp por frank jc
NacpNacp
Nacp
frank jc35.2K vistas
NATIONAL AIDS CONTROL PROGRAMME IN INDIA por Bharat Masal
NATIONAL AIDS CONTROL PROGRAMME IN INDIANATIONAL AIDS CONTROL PROGRAMME IN INDIA
NATIONAL AIDS CONTROL PROGRAMME IN INDIA
Bharat Masal34.8K vistas
Prevention of Mother to Child Transmission of HIV 2017 por Helen Madamba
Prevention of Mother to Child Transmission of HIV 2017Prevention of Mother to Child Transmission of HIV 2017
Prevention of Mother to Child Transmission of HIV 2017
Helen Madamba15.6K vistas
National leprosy eradication program CHN por NehaNupur8
National leprosy eradication program CHNNational leprosy eradication program CHN
National leprosy eradication program CHN
NehaNupur81.1K vistas
National Aids Control Program por MD Renaissance
National Aids Control ProgramNational Aids Control Program
National Aids Control Program
MD Renaissance517 vistas
Dr irma asuncion hb liver ca summit por Alex Asuncion
Dr irma asuncion hb liver ca summitDr irma asuncion hb liver ca summit
Dr irma asuncion hb liver ca summit
Alex Asuncion962 vistas
Tb programme por frank jc
Tb programmeTb programme
Tb programme
frank jc17.2K vistas
National health programm por Purvi Patel
National health programmNational health programm
National health programm
Purvi Patel2.5K vistas
Leprosy management challenges por ArunSharma10
Leprosy management challengesLeprosy management challenges
Leprosy management challenges
ArunSharma101.4K vistas
Nacp iii&iv.pptx por DrAnup Kumar
Nacp iii&iv.pptxNacp iii&iv.pptx
Nacp iii&iv.pptx
DrAnup Kumar231 vistas
National Leprosy Eradication Program - Dr Surendran Venkataraman por Surendran Venkataraman
National Leprosy Eradication Program - Dr Surendran VenkataramanNational Leprosy Eradication Program - Dr Surendran Venkataraman
National Leprosy Eradication Program - Dr Surendran Venkataraman
Surendran Venkataraman12.4K vistas

Más de DrHeena tiwari

Dm por
DmDm
DmDrHeena tiwari
99 vistas27 diapositivas
Performance evaluation ppt por
Performance evaluation ppt Performance evaluation ppt
Performance evaluation ppt DrHeena tiwari
319 vistas13 diapositivas
Evaluation of Signs and Symptoms Post Recovery in COVID Patients: A Questionn... por
Evaluation of Signs and Symptoms Post Recovery in COVID Patients: A Questionn...Evaluation of Signs and Symptoms Post Recovery in COVID Patients: A Questionn...
Evaluation of Signs and Symptoms Post Recovery in COVID Patients: A Questionn...DrHeena tiwari
91 vistas6 diapositivas
Marginal and Internal Fit of Different Fixed Dental Prostheses: A Comparative... por
Marginal and Internal Fit of Different Fixed Dental Prostheses: A Comparative...Marginal and Internal Fit of Different Fixed Dental Prostheses: A Comparative...
Marginal and Internal Fit of Different Fixed Dental Prostheses: A Comparative...DrHeena tiwari
80 vistas7 diapositivas
Evaluation of Physical &; Mental Status of COVID Recovered Patients Underwent... por
Evaluation of Physical &; Mental Status of COVID Recovered Patients Underwent...Evaluation of Physical &; Mental Status of COVID Recovered Patients Underwent...
Evaluation of Physical &; Mental Status of COVID Recovered Patients Underwent...DrHeena tiwari
62 vistas6 diapositivas
EFFICACY OF FIXED VERSUS REMOVAL RETAINER POST ORTHODONTIC TREATMENT: A COMP... por
 EFFICACY OF FIXED VERSUS REMOVAL RETAINER POST ORTHODONTIC TREATMENT: A COMP... EFFICACY OF FIXED VERSUS REMOVAL RETAINER POST ORTHODONTIC TREATMENT: A COMP...
EFFICACY OF FIXED VERSUS REMOVAL RETAINER POST ORTHODONTIC TREATMENT: A COMP...DrHeena tiwari
80 vistas7 diapositivas

Más de DrHeena tiwari(20)

Performance evaluation ppt por DrHeena tiwari
Performance evaluation ppt Performance evaluation ppt
Performance evaluation ppt
DrHeena tiwari319 vistas
Evaluation of Signs and Symptoms Post Recovery in COVID Patients: A Questionn... por DrHeena tiwari
Evaluation of Signs and Symptoms Post Recovery in COVID Patients: A Questionn...Evaluation of Signs and Symptoms Post Recovery in COVID Patients: A Questionn...
Evaluation of Signs and Symptoms Post Recovery in COVID Patients: A Questionn...
DrHeena tiwari91 vistas
Marginal and Internal Fit of Different Fixed Dental Prostheses: A Comparative... por DrHeena tiwari
Marginal and Internal Fit of Different Fixed Dental Prostheses: A Comparative...Marginal and Internal Fit of Different Fixed Dental Prostheses: A Comparative...
Marginal and Internal Fit of Different Fixed Dental Prostheses: A Comparative...
DrHeena tiwari80 vistas
Evaluation of Physical &; Mental Status of COVID Recovered Patients Underwent... por DrHeena tiwari
Evaluation of Physical &; Mental Status of COVID Recovered Patients Underwent...Evaluation of Physical &; Mental Status of COVID Recovered Patients Underwent...
Evaluation of Physical &; Mental Status of COVID Recovered Patients Underwent...
DrHeena tiwari62 vistas
EFFICACY OF FIXED VERSUS REMOVAL RETAINER POST ORTHODONTIC TREATMENT: A COMP... por DrHeena tiwari
 EFFICACY OF FIXED VERSUS REMOVAL RETAINER POST ORTHODONTIC TREATMENT: A COMP... EFFICACY OF FIXED VERSUS REMOVAL RETAINER POST ORTHODONTIC TREATMENT: A COMP...
EFFICACY OF FIXED VERSUS REMOVAL RETAINER POST ORTHODONTIC TREATMENT: A COMP...
DrHeena tiwari80 vistas
Evaluation of Efficiency of Composite Veneers Vs Porcelain Veneers in Dental... por DrHeena tiwari
 Evaluation of Efficiency of Composite Veneers Vs Porcelain Veneers in Dental... Evaluation of Efficiency of Composite Veneers Vs Porcelain Veneers in Dental...
Evaluation of Efficiency of Composite Veneers Vs Porcelain Veneers in Dental...
DrHeena tiwari82 vistas
Oral Health & Its Effect on COVID 19: Systematic Review & Meta Analysis. por DrHeena tiwari
Oral Health & Its Effect on COVID 19: Systematic Review & Meta Analysis.Oral Health & Its Effect on COVID 19: Systematic Review & Meta Analysis.
Oral Health & Its Effect on COVID 19: Systematic Review & Meta Analysis.
DrHeena tiwari66 vistas
Radiographic Evaluation of the MB2 Canal in Permanent Maxillary Molars- An Or... por DrHeena tiwari
Radiographic Evaluation of the MB2 Canal in Permanent Maxillary Molars- An Or...Radiographic Evaluation of the MB2 Canal in Permanent Maxillary Molars- An Or...
Radiographic Evaluation of the MB2 Canal in Permanent Maxillary Molars- An Or...
DrHeena tiwari172 vistas
EFFECT OF DIFFERENT FLUORIDE VARNISHES IN PREVENTION OF CARIES ON MANDIBULAR ... por DrHeena tiwari
EFFECT OF DIFFERENT FLUORIDE VARNISHES IN PREVENTION OF CARIES ON MANDIBULAR ...EFFECT OF DIFFERENT FLUORIDE VARNISHES IN PREVENTION OF CARIES ON MANDIBULAR ...
EFFECT OF DIFFERENT FLUORIDE VARNISHES IN PREVENTION OF CARIES ON MANDIBULAR ...
DrHeena tiwari72 vistas
EVALUATION OF BREAST CANCER AND ITS RELATION WITH PERIODONTAL DISEASES: AN OR... por DrHeena tiwari
EVALUATION OF BREAST CANCER AND ITS RELATION WITH PERIODONTAL DISEASES: AN OR...EVALUATION OF BREAST CANCER AND ITS RELATION WITH PERIODONTAL DISEASES: AN OR...
EVALUATION OF BREAST CANCER AND ITS RELATION WITH PERIODONTAL DISEASES: AN OR...
DrHeena tiwari99 vistas
EVALUATION OF EFFICIENCY IN CAST PARTIAL DENTURES VERSUS ACRYLIC PARTIAL DENT... por DrHeena tiwari
EVALUATION OF EFFICIENCY IN CAST PARTIAL DENTURES VERSUS ACRYLIC PARTIAL DENT...EVALUATION OF EFFICIENCY IN CAST PARTIAL DENTURES VERSUS ACRYLIC PARTIAL DENT...
EVALUATION OF EFFICIENCY IN CAST PARTIAL DENTURES VERSUS ACRYLIC PARTIAL DENT...
DrHeena tiwari101 vistas
EFFECT OF RADIOGRAPHIC & HISTOPATHOLOGIC VARIANTS IN MANAGEMENT OF AMELOBLAST... por DrHeena tiwari
EFFECT OF RADIOGRAPHIC & HISTOPATHOLOGIC VARIANTS IN MANAGEMENT OF AMELOBLAST...EFFECT OF RADIOGRAPHIC & HISTOPATHOLOGIC VARIANTS IN MANAGEMENT OF AMELOBLAST...
EFFECT OF RADIOGRAPHIC & HISTOPATHOLOGIC VARIANTS IN MANAGEMENT OF AMELOBLAST...
DrHeena tiwari73 vistas
CLINICAL FEATURES, DIFFERENCES IN COVID FIRST, SECOND, THIRD WAVES- A DATA BA... por DrHeena tiwari
CLINICAL FEATURES, DIFFERENCES IN COVID FIRST, SECOND, THIRD WAVES- A DATA BA...CLINICAL FEATURES, DIFFERENCES IN COVID FIRST, SECOND, THIRD WAVES- A DATA BA...
CLINICAL FEATURES, DIFFERENCES IN COVID FIRST, SECOND, THIRD WAVES- A DATA BA...
DrHeena tiwari75 vistas
EVALUATION OF THE PERIODONTAL STATUS OF DIABETES MELLITUS PATIENTS WITH NORM... por DrHeena tiwari
 EVALUATION OF THE PERIODONTAL STATUS OF DIABETES MELLITUS PATIENTS WITH NORM... EVALUATION OF THE PERIODONTAL STATUS OF DIABETES MELLITUS PATIENTS WITH NORM...
EVALUATION OF THE PERIODONTAL STATUS OF DIABETES MELLITUS PATIENTS WITH NORM...
DrHeena tiwari69 vistas
COMPARISON OF THE INTERLEUKIN-33 AMONG THE HEALTHY AND AGGRESSIVE PERIODONTIT... por DrHeena tiwari
COMPARISON OF THE INTERLEUKIN-33 AMONG THE HEALTHY AND AGGRESSIVE PERIODONTIT...COMPARISON OF THE INTERLEUKIN-33 AMONG THE HEALTHY AND AGGRESSIVE PERIODONTIT...
COMPARISON OF THE INTERLEUKIN-33 AMONG THE HEALTHY AND AGGRESSIVE PERIODONTIT...
DrHeena tiwari50 vistas
An Epidemiological Data of Oral Health Status and Treatment Needs in Pamulapa... por DrHeena tiwari
An Epidemiological Data of Oral Health Status and Treatment Needs in Pamulapa...An Epidemiological Data of Oral Health Status and Treatment Needs in Pamulapa...
An Epidemiological Data of Oral Health Status and Treatment Needs in Pamulapa...
DrHeena tiwari63 vistas
Evaluation of efficiency of complete dentures using BPS, Lecutonite& Acry... por DrHeena tiwari
Evaluation of efficiency of complete dentures using BPS, Lecutonite& Acry...Evaluation of efficiency of complete dentures using BPS, Lecutonite& Acry...
Evaluation of efficiency of complete dentures using BPS, Lecutonite& Acry...
DrHeena tiwari13 vistas
An Evaluation of Short Term Success and Survival Rate of Implants Placed in F... por DrHeena tiwari
An Evaluation of Short Term Success and Survival Rate of Implants Placed in F...An Evaluation of Short Term Success and Survival Rate of Implants Placed in F...
An Evaluation of Short Term Success and Survival Rate of Implants Placed in F...
DrHeena tiwari10 vistas
Evaluation of Cardiac Complications in Pateint Undergoing COVID 19 Treatment:... por DrHeena tiwari
Evaluation of Cardiac Complications in Pateint Undergoing COVID 19 Treatment:...Evaluation of Cardiac Complications in Pateint Undergoing COVID 19 Treatment:...
Evaluation of Cardiac Complications in Pateint Undergoing COVID 19 Treatment:...
DrHeena tiwari76 vistas

Último

Biomedicine & Pharmacotherapy por
Biomedicine & PharmacotherapyBiomedicine & Pharmacotherapy
Biomedicine & PharmacotherapyTrustlife
220 vistas12 diapositivas
The A-Team Against Relapsed/Refractory Myeloma: Community Strategies for Enha... por
The A-Team Against Relapsed/Refractory Myeloma: Community Strategies for Enha...The A-Team Against Relapsed/Refractory Myeloma: Community Strategies for Enha...
The A-Team Against Relapsed/Refractory Myeloma: Community Strategies for Enha...PVI, PeerView Institute for Medical Education
14 vistas44 diapositivas
BODY COMPOSITION.pptx por
BODY COMPOSITION.pptxBODY COMPOSITION.pptx
BODY COMPOSITION.pptxAneriPatwari
50 vistas46 diapositivas
Scrotal and Testicular Swelling.pptx por
Scrotal and Testicular Swelling.pptxScrotal and Testicular Swelling.pptx
Scrotal and Testicular Swelling.pptxMichael Sintayehu
23 vistas74 diapositivas
The Art of naming drugs.pptx por
The Art of naming drugs.pptxThe Art of naming drugs.pptx
The Art of naming drugs.pptxDanaKarem1
25 vistas48 diapositivas
vitamin E.pptx por
vitamin E.pptxvitamin E.pptx
vitamin E.pptxajithkilpart
15 vistas14 diapositivas

Último(20)

Biomedicine & Pharmacotherapy por Trustlife
Biomedicine & PharmacotherapyBiomedicine & Pharmacotherapy
Biomedicine & Pharmacotherapy
Trustlife220 vistas
The Art of naming drugs.pptx por DanaKarem1
The Art of naming drugs.pptxThe Art of naming drugs.pptx
The Art of naming drugs.pptx
DanaKarem125 vistas
Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP por MohamadAlhes
Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDPChronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP
Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP
MohamadAlhes89 vistas
Myocardial Infarction Nursing.pptx por Asraf Hussain
Myocardial Infarction Nursing.pptxMyocardial Infarction Nursing.pptx
Myocardial Infarction Nursing.pptx
Asraf Hussain22 vistas
GAS CHROMATOGRAPHY-Principle, Instrumentation Advantage and disadvantage appl... por DipeshGamare
GAS CHROMATOGRAPHY-Principle, Instrumentation Advantage and disadvantage appl...GAS CHROMATOGRAPHY-Principle, Instrumentation Advantage and disadvantage appl...
GAS CHROMATOGRAPHY-Principle, Instrumentation Advantage and disadvantage appl...
DipeshGamare18 vistas
PATIENTCOUNSELLING in.pptx por skShashi1
PATIENTCOUNSELLING  in.pptxPATIENTCOUNSELLING  in.pptx
PATIENTCOUNSELLING in.pptx
skShashi145 vistas
Buccoadhesive drug delivery System.pptx por ABG
Buccoadhesive drug delivery System.pptxBuccoadhesive drug delivery System.pptx
Buccoadhesive drug delivery System.pptx
ABG167 vistas
Vyadhikshmatva.pptx 1.pptx por Akshay Shetty
Vyadhikshmatva.pptx 1.pptxVyadhikshmatva.pptx 1.pptx
Vyadhikshmatva.pptx 1.pptx
Akshay Shetty53 vistas
INTRODUCTION TO PHARMACEUTICAL VALIDATION SCOPE and MERITS OF VALIDATION.pptx por ABG
INTRODUCTION TO PHARMACEUTICAL VALIDATION SCOPE and MERITS OF VALIDATION.pptxINTRODUCTION TO PHARMACEUTICAL VALIDATION SCOPE and MERITS OF VALIDATION.pptx
INTRODUCTION TO PHARMACEUTICAL VALIDATION SCOPE and MERITS OF VALIDATION.pptx
ABG120 vistas
Complications & Solutions in Laparoscopic Hernia Surgery.pptx por Varunraju9
Complications & Solutions in Laparoscopic Hernia Surgery.pptxComplications & Solutions in Laparoscopic Hernia Surgery.pptx
Complications & Solutions in Laparoscopic Hernia Surgery.pptx
Varunraju9135 vistas
eTEP -RS Dr.TVR.pptx por Varunraju9
eTEP -RS Dr.TVR.pptxeTEP -RS Dr.TVR.pptx
eTEP -RS Dr.TVR.pptx
Varunraju9148 vistas

Malaria ppt

  • 1. MALARIA PRESENTER Dr. HEENA DIXIT GUIDE Dr. KRUPALI PATEL 05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 1
  • 2. CONTENTS • INTRODUCTION • PROBLEM STATEMENT • EPIDEMIOLOGICAL TYPES • EPIDEMIOLOGICAL DETERMINANTS • MEASUREMENT • DISEASE CONTROL • INTERVENTIONS • GLOBAL STRATEGY 05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 2
  • 3. INTRODUCTION 05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 3
  • 4. PROBLEM STATEMENT- WORLD • 2016- 91 COUNTIRES- 216 MILLION CASES- 4,45,000 DEATHS • 2010 TO 2016- 18% DECREASE IN INCIDENCE AMONG POPULATION AT RISK GLOBALLY. • MAXIMUM BURDEN- SUB SHARAN REGION • RISK GROUPS: • YOUNG CHILDRENS • NON / SEMI IMMUNE/ HIV- PREGNANT WOMEN • AIDS PATIENTS • INTERNATIONAL TRAVELLERS • IMMIGRANT & FAMILY- NON ENDEMIC AREAS • ETHNIC & TRIBALS 05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 4
  • 5. PROBLEM STATEMENT- INDIA • India shared 2% of the total global malaria cases in 2019 • PALSMODIUM FALCIPARUM • 21.98% POPULATION- HIGH TRANSMISSION AREAS (>1:1000 RATIO) • 67% POPULATION- LOW TRANSMISSION AREAS (0-1:1000 RATIO) • 91% CASES & 99% DEATHS- NORTH EAST & CENTRAL REGION • 2000-2013- CASES DECLINE BY 58.63%- 2.03 TO 0.84 MILLION • 2000-2013- DEATH DECLINE BY 88.85%- 932 TO 104 ANNUALLY • 1° VECTORS- An. Culicifacies. An. Stephensi, An. Fluviatilis, An. Minimus, An. Birus, An. Epiroticus. 05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 5
  • 6. EPIDEMIOLOGICAL TYPES • TRIBAL • RURAL • URBAN • PROJECT AREA • BORDER • FOREST • FLOODS 05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 6
  • 7. EPIDEMIOLOGICAL DETERMINANTS AGENT FACTORS • AGENT • RESERVOIR OF INFECTION • PERIOD OF COMMUNICABILITY HOST FACTORS • AGE • SEX • RACE • PREGNANCY • SOCIOECONOMIC DEVELOPMENT • HOUSING • POPULATION MOBILITY • OCCUPATION • HUMAN HABITS • IMMUNITY ENVIRONMENTAL FACTORS • SEASON • TEMPRATURE • HUMIDITY • RAINFALL • ALTITUDE • MAN MADE MALARIA 05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 7
  • 8. MODE OF TRANSMISSION • VECTOR • DIRECT • CONGENITAL 05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 8 INCUBATION PERIODS • FALCIPARUM- 12 DAYS (9 TO 14) • VIVAX- 14 DAYS (8 TO 17) • QUARTAN- 28 DAYS (18 TO 40) • OVALE- 17 DAYS (6 TO 18) • VIVAX- FEW STRAINS- 9 MONTHS (UNDER SUPPRESSIVE ANTIMALARIAL DRUGS)
  • 9. CLINICAL FEATURES DIAGNOSIS • MICROSCOPY • SEROLOGICAL TEST • RAPID DIAGNOSTIC TEST 05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 9
  • 10. MEASUREMENT • PRE ERADICATION ERA • SPLEEN RATE • AVERAGE ENLARGED SPLEEN • PARASITE RATE • PARASITE DENSITY INDEX • INFANT PARASITE RATE • PROPOTIONAL CASE RATE 05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 10 • ERADICATION ERA • ANNUAL PARASITE INCIDENCE • ANNUAL BLOOD EXMAINATION RATE • ANNUAL FALCIPARUM INCIDENCE • SLIDE POSITIVITY RATE • SLIDE FALCIPARUM RATE VECTOR INDICES • HUMAN BLOOD INDEX • SPOROZOITE RATE • MOSQUITO DENSITY • MAN BITING RATE • ENOCULATION RATE
  • 11. DISEASE CONTROL 05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 11
  • 12. 05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 12
  • 13. 05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 13
  • 14. ACTIVE INTERVENTION MEASURES 05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 14
  • 15. MALARIA VECTOR CONTROLL MEASURES 05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 15
  • 16. GLOBAL STRATEGY- NMCP & VACCINES 05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 16
  • 17. Global Malaria Elimination scenario: • Since 1900, 127 countries have registered malaria elimination. In 2021, two countries El Salvador on February 25 and China on June 29 were declared malaria-free by the WHO. • China followed some specific strategies, namely strong surveillance following the ‘1-3-7’system: malaria diagnosis within 1 day, 3 days for case investigation and by day 7 for public health responses. • Molecular Malaria Surveillance for drug resistance and genome-based approaches to distinguish between indigenous and imported cases was conducted. All borders to the neighbouring countries were thoroughly screened to prevent the entry of unwanted malaria into the country. • Srilanka could achieve elimination by deploying malaria mobile clinics besides strengthening surveillance system. 05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 17
  • 18. NATIONAL MALARIA CONTROL PROGRAMME • Began as NMCP in 1953. • Following are main activities of NMCP: • Formulating policies and guidelines. • Technical guidance. • Planning. • Logistics. • Monitoring and evaluation. • Coordination of activities through the states/union Territories and in consultation with national organisations such as National Centre for Disease Control National Institute of Malaria Research. • Collaboration with international oraganisations.. • Training • Fascilitating research • Coordinating control activities in the inter-state and inter-country border areas. 05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 18
  • 19. MOSQUIRIX • A recombinent protein based malaria vaccine • WHO is recommending widespread use of the RTS,S/AS01 (RTS,S) malaria vaccine among children in sub-Saharan Africa and in other regions with moderate to high P. falciparum malaria transmission. • Malaria vaccine should be provided in a schedule of 4 doses in children from 5 months of age for the reduction of malaria disease and burden. 05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 19
  • 20. URBAN MALARIA SCHEME • Launched in november 1971 to interrupt or reduce malaria tranmission in towns and cities. • Current strategy: • Anti-larval measures on weekly intervals. • Source reduction i.e.land filling/drainage through minor engineering methods. • Biological control by introduction of larvivorous fish. • Anti-parasitic measures through passive surveillance for detection of cases and complete treatment. 05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 20
  • 21. TRIBAL MALARIA ACTION PLAN • Predominant parasite species in triabl areis Falciparum. • Objective is to reduce large reservoir of Falciparum in triabal population. • Priority of villages according to degree of risk i.e.high proportion of Pf cases, type of vectors,forest based economy,outdoor sleeping habits etc. for vector control measures(IRS,LLINs or treatment of community owned bed nets with insecticides), social marketing to increase spray coverageandusage of bed nets, community mobilisation by utilising traditional IEC/BCC tools practices. • In Forest areas where accessibility of workers /volunteers is impeded due to elephants , involvement of forest department in diagnosis and treatment by deleneation of such areas can be explored. 05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 21
  • 22. THANK YOU FOR YOUR PATIENCE LISTENING WORLD MALARIA DAY 25TH APRIL YEARLY MALARIA WEEK -JUNE 05-04-2022 19:46:47 Dr. HEENA/MALARIA/PPT/MPH 22